Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country

Pediatric Blood & Cancer
Frederick W ThielenHedwig M Blommestein

Abstract

While multiple studies have examined the cost of health care for one aspect of sickle cell disease care, few have focussed on the overall cost of comprehensive care for sickle cell disease. We conducted a retrospective cohort study of children with sickle cell disease treated in a comprehensive care centre from 1 January 2015 to 31 December 2016. Health care utilisation of included patients was based upon data from two main sources. The clinical practice guideline was used to determine the expected resource use of routine comprehensive care (planned elective care), and the financial claims database was used to estimate real-world resource use associated with acute and inpatient care (additional care). A total of 125 children with sickle cell disease were analysed. Expenditures for these patients averaged €5049 [standard deviation (SD) €1634] per child per year. Total yearly costs per patient varied considerably, ranging from €669 to €84 010, and less than 15% of patients were responsible for 50% of the health care costs. The majority (37%) of costs was associated with inpatient hospital care, which increased by age group, 27% with diagnostics, 19% with treatment, 11% with outpatients' visits and 6% with emergency care. We have ...Continue Reading

References

Oct 6, 1997·The International Journal of Clinical and Experimental Hypnosis·D F DingesM T Orne
Dec 18, 1998·Journal of Pediatric Hematology/oncology·J H BilenkerG F Anderson
Oct 19, 1999·Journal of Pediatric Hematology/oncology·P J NietertM D Silverstein
Apr 24, 2001·Archives of Disease in Childhood·K ArmonS Smith
Jul 23, 2008·International Journal of Laboratory Hematology·G R SerjeantD R Higgs
Oct 8, 2008·Pediatric Blood & Cancer·Jean L RaphaelAngelo P Giardino
Apr 10, 2009·American Journal of Hematology·Teresa L KaufAbraham G Hartzema
May 6, 2009·American Journal of Hematology·Samir K Ballas
Mar 3, 2010·Blood·Charles T QuinnGeorge R Buchanan
Jan 24, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Staci D ArnoldPrakash Satwani
Dec 2, 2015·ClinicoEconomics and Outcomes Research : CEOR·Oladele Simeon OlatunyaOdunayo Aderiye
Jul 22, 2016·Blood·Kate GardnerSwee Lay Thein
Aug 13, 2017·Pediatric Blood & Cancer·Laura M Bou-MarounGregory A Yanik
Oct 20, 2018·British Journal of Haematology·Stephan LobitzUNKNOWN with the endorsement of EuroBloodNet, the European Reference Network in Rare Haematological Diseases
Jul 6, 2019·PloS One·Nirmish ShahHuseyin Yuce

❮ Previous
Next ❯

Citations

Oct 27, 2021·Pediatric Blood & Cancer·Maite E HouwingLotte Haverman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.